Big Pharma Fails 50% of the Time in Phase Three. AI Can Fix That | Vin Singh, BullFrog AI

It costs up to $2 billion and fifteen years to develop a drug, and big pharma still fails half the time at the final stage. BullFrog AI founder, Chairman, and CEO Vin Singh joins Craig Smith with a clear diagnosis of why: the industry keeps picking the wrong drug target from the beginning, and no amount of downstream optimization fixes a fundamentally wrong starting point. Built on AI technology originally developed at Johns Hopkins' Applied Physics Lab, BullFrog has assembled a three-stage platform that cleans messy clinical data, runs causal analysis to map disease pathways, and then ranks c